Posted by - UniqueThis
-
on - Jul 22 -
Filed in - Health -
-
60 Views -
0 Comments -
0 Likes -
0 Reviews
Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that have attracted attention from regulators